Emerging Alzheimer's disease therapies: Focusing on the future

September 27, 2001

Who: John Q. Trojanowski, MD, PhD, co-director University of Pennsylvania Center for Neurodegenerative Disease Research, Virginia M. -Y. Lee PhD, co-director University of Pennsylvania Center for Neurodegenerative Disease Research, And many of the leading researchers in the field of Alzheimer's Disease therapy.

What: A day-long retreat at the University of Pennsylvania Medical Center to focus on the state of the art in the field of Alzheimer's Disease therapy research. The conference will bring together world-renowned leaders in the field to discuss innovative research approaches and the future of Alzheimer's Disease treatment

When: Wednesday, November 7th, 2001 8:30AM - 6:00 PM

Where: Dunlop Auditorium
Stemmler Hall
36th & Hamilton Walk
Philadelphia, PA 10104
Editor's note: Please contact Greg Lester 215-349-5658 if you plan to attend all or part of the retreat - especially if you will be attending lunch. For directions and the entire schedule of the day's speakers and topics, visit the Web at http://www.med.upenn.edu/cndr

University of Pennsylvania School of Medicine

Related Disease Therapy Articles from Brightsurf:

Biologic therapy for psoriasis may reduce heart disease
Biologic therapy for psoriasis - protein-based infusions to suppress inflammation - was associated with a significant reduction in high-risk plaque in heart arteries, over one-year, according to new research.

New marine molecules with therapy potential against Alzheimer's disease
An interdisciplinary research study of the University of Barcelona identified two potential candidates to treat Alzheimer's disease.

Potential therapy for rare neurologic disease
A targeted therapy, currently being studied for treatment of certain cancers including glioblastoma, may also be beneficial in treating other neurologic diseases, a study at the University of Cincinnati shows.

Online therapy helped cardiovascular disease patients with depression
Researchers at Linköping University have developed a treatment for depression among people with cardiovascular disease.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Smart brain stimulators: Next-gen Parkinson's disease therapy
Researchers at the University of Houston have found neuro biomarkers for Parkinson's disease that can help create the next generation of 'smart' deep brain stimulators, able to respond to specific needs of Parkinson's disease patients.

Kidney disease killer vulnerable to targeted nano therapy
By loading a chelation drug into a nano-sized homing device, researchers at Clemson University have reversed in an animal model the deadliest effects of chronic kidney disease, which kills more people in the United States each year than breast or prostate cancer.

Possible pathway to new therapy for Alzheimer's disease
Researchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of beta-amyloid protein, the toxic initiator of Alzheimer's disease (AD).

Improving cell replacement therapy for Parkinson's disease
Researchers describe a new set of cell surface markers on dopaminergic progenitor cells, which allow isolation of a more beneficial population of induced neurons for cell replacement therapy.

Hyperbaric oxygen therapy may alleviate symptoms of Alzheimer's Disease
A new Tel Aviv University study reveals that hyperbaric oxygen treatments may alleviate symptoms experienced by patients with Alzheimer's disease.

Read More: Disease Therapy News and Disease Therapy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.